Fawcett Mark
- SEC CIK
- 0001664134
No open-market purchases or sales filed in the past year.
Current role at each company
- ASTH Astrana Health, Inc.Directoras of Jan 24, 2022
- NUTX Nutex Health Inc.Directoras of Dec 21, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Fawcett Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NUTX Nutex Health Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2021 (view filing) | Mar 21, 2019-Aug 5, 2020 | 1,006 daysLate | Fawcett MarkDirector | PPurchase | +88.7K | $6.67 | +$24.0K | –3.60K after | Derivative2 lots |